Ruben S. A. Goedegebuure

Amsterdam University Medical Centers — Netherlands

Medicine · Health Sciences

9h-index297citations19works4.52yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Esophageal Cancer Research and Treatment(7), interferon and immune responses(5), Cancer Immunotherapy and Biomarkers(4), Gastric Cancer Management and Outcomes(4), Pancreatic and Hepatic Oncology Research(3)

Publications19 total

Malignancies of the small intestine: incidence and trends in a nationwide registry
Cancer Epidemiology·2025Open Access
Treatment with checkpoint inhibitors for unresectable non-metastatic mismatch repair deficient intestinal cancer; a case series
BJC Reports·2025· 2 citedOpen Access
Fecal, duodenal, and tumor microbiota composition of esophageal carcinoma patients, a longitudinal prospective cohort
JNCI Journal of the National Cancer Institute·2024· 6 citedOpen Access
Phenotypic immune characterization of gastric and esophageal adenocarcinomas reveals profound immune suppression in esophageal tumor locations
Frontiers in Immunology·2024· 10 citedOpen Access
Interferon- and STING-independent induction of type I interferon stimulated genes during fractionated irradiation
Journal of Experimental & Clinical Cancer Research·2021· 29 citedOpen Access
Molecular profiles of response to neoadjuvant chemoradiotherapy in oesophageal cancers to develop personalized treatment strategies
Molecular Oncology·2021· 10 citedOpen Access
Author response for "Molecular profiles of response to neoadjuvant chemoradiotherapy in oesophageal cancers to develop personalized treatment strategies"
2021
Additional file 2 of Interferon- and STING-independent induction of type I interferon stimulated genes during fractionated irradiation
Figshare·2021Open Access
Pre-treatment tumor-infiltrating T cells influence response to neoadjuvant chemoradiotherapy in esophageal adenocarcinoma
OncoImmunology·2021· 33 citedOpen Access
A Phase I Open-Label Clinical Trial Evaluating the Therapeutic Vaccine hVEGF26–104/RFASE in Patients with Advanced Solid Malignancies
The Oncologist·2020· 8 citedOpen Access
Development of transient radioresistance during fractionated irradiation in vitro
Radiotherapy and Oncology·2020· 15 cited
Combining Radiation Therapy With Interferons: Back to the Future
International Journal of Radiation Oncology*Biology*Physics·2020· 15 cited
[Non-metastatic oesophageal cancer: diagnosis and treatment].
PubMed·2019· 1 cited
Abstract 3738: A STING independent type-1 interferon response induced by fractionated radiotherapy coincides with altered tumor growth and clonogenicity
Tumor Biology·2019Open Access
Abstract 3738: A STING independent type-1 interferon response induced by fractionated radiotherapy coincides with altered tumor growth and clonogenicity
Cancer Research·2019
Combining Radiotherapy With Anti-angiogenic Therapy and Immunotherapy; A Therapeutic Triad for Cancer?
Frontiers in Immunology·2019· 103 citedOpen Access
Niet-gemetastaseerde slokdarmkanker
Pure Amsterdam UMC·2019
Phase 1 study of everolimus and low-dose oral cyclophosphamide in patients with metastatic renal cell carcinoma
Cancer Immunology Immunotherapy·2018· 15 citedOpen Access
Hysteroscopic Sterilization Using a Virtual Reality Simulator: Assessment of Learning Curve
Journal of Minimally Invasive Gynecology·2013· 50 cited

Frequent Co-authors

Victor L. Thijssen(11), Sarah Derks(10), Henk M.W. Verheul(9), Nicole C.T. van Grieken(6), Kitty C. M. Castricum(5), Jaap van den Berg(5), Ben J. Slotman(5), Leonie K. de Klerk(4), Adam J. Bass(4), Tanja D. de Gruijl(4), Esther A. Kleibeuker(4), Maarten Jacobs(4), Adrian L. Harris(4), Donald L. van der Peet(4), Hans van Vliet(3), Arantza Fariña Sarasqueta(3), Micaela Harrasser(2), Tessa S. Groen-van Schooten(2), Mark I. van Berge Henegouwen(2), Roos E. Pouw(2)